Innovation Pharmaceuticals Inc (IPIX)

[Scottwny]

Thanks BK, that makes sense. With 400,000 cases in the US per year, I'm hoping this trial can wrap up quickly. I think I remember there being a competitive drug in trials that was slowing us down (I think that failed?), but we have 12 sites recruiting, so we just need to average about 5 OM cases per trial site.

Do you know how it is decided which patients get drug vs. placebo? I'm wondering if drug vs. placebo is usually evenly distributed (i.e. we should expect interim results to have about 50% drug 50% placebo). With 80-100% of head and neck cancer patients developing OM, it should be pretty easy to analyze interim data.

Another random question, we say there are 400,000 cases in the US, but once we have an approved drug, is it easy to sell across the world (why just look at number of cases in US)?